Recap: Quest Diagnostics Q4 Earnings

Quest Diagnostics DGX reported its Q4 earnings results on Thursday, February 3, 2022 at 06:45 AM.

Here's what investors need to know about the announcement.

Quest Diagnostics beat estimated earnings by 5.05%, reporting an EPS of $3.33 versus an estimate of $3.17, which did not surprise analysts.

Revenue was up $258.00 million from the same period last year.

Last quarter the company beat on EPS by $1.09, which was followed by a 0.78% increase in the share price the next day.

Here's a look at Quest Diagnostics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	2.87	2.86	3.71	4.24
EPS Actual	3.96	3.18	3.76	4.48
Revenue Estimate	2.45B	2.38B	2.64B	2.93B
Revenue Actual	2.77B	2.55B	2.72B	3.00B

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Quest Diagnostics management provided guidance for their next quarter, expecting earnings between $8.65 and $9.35 per share for the next quarter.

This represents a 170.27% in quarter-over-quarter growth for Quest Diagnostics, a bullish signal to many investors.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.